Sarah Schlesinger

Director-Education & Training & Associate Professor at The Rockefeller University

Sarah Schlesinger

Sarah Schlesinger

Director-Education & Training & Associate Professor at The Rockefeller University

Overview
RelSci Relationships

1226

Number of Boards

11

Birthday

1960

Age

60

Contact Data
Trying to get in touch with Sarah Schlesinger? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Sarah Schlesinger likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder & Chair at Metabiota, Inc.

Relationship likelihood: Strong

President at The Rockefeller University

Relationship likelihood: Strong

Head of Laboratory, Laboratory of Cell Biology & Genetics at The Rockefeller University

Relationship likelihood: Strong

Professor, Head of Laborat at The Rockefeller University

Relationship likelihood: Strong

Scientific Director & Chief Executive Officer, Aaron Diamond AIDS Research Center at The Rockefeller University

Relationship likelihood: Strong

Vice President & Chief Investment Officer at The Rockefeller University

Relationship likelihood: Strong

Head, Laboratory of Yeast Genetics & Cell Biology at The Rockefeller University

Relationship likelihood: Strong

Head, Plant Molecular Biology Laboratory at The Rockefeller University

Relationship likelihood: Strong

Head, Leonard Wagner Laboratory of Molecular Genetics & Immunology at The Rockefeller University

Relationship likelihood: Strong

Head, Lulu & Anthony Wang Laboratory of Neural Circuits & Behavior at The Rockefeller University

Relationship likelihood: Strong

Paths to Sarah Schlesinger
Potential Connections via
Relationship Science
You
Sarah Schlesinger
Director-Education & Training & Associate Professor at The Rockefeller University
Education

Wellesley is known for the excellence of its education, the beauty of its setting, its gifted faculty, and the uniqueness of its campus culture. But most of all, Wellesley is known for the thousands of accomplished, thoughtful women it has sent out into the world for over 100 years—women who are committed to making a difference. A Transformative Educational Experience Every year, some 2,400 of the world’s top undergraduate women are challenged to exceed their own highest personal and intellectual expectations. The mastery Wellesley graduates demonstrate across the professional and vocational spectrum, and the influence they wield—whether in their own communities or on the world stage—is testament to a singularly empowering undergraduate experience. Wellesley’s lively academic community places a high value on rigorous, probing inquiry, and creative, cross-discipline thinking. Its collaborative approach to scholarship encourages students to question, debate, and refine their points of view, not only with each other, but with our world-class faculty—often by working directly with them on groundbreaking projects. A Wellesley education fosters the highest standard of readiness for the “real world” in its graduates, in terms of ability to think, act, and contribute meaningfully and effectively in their chosen areas of interest. The “Full-Engagement” Advantage Wellesley’s full-engagement academic philosophy extends to the running of the College itself. The student voice is central to decision-making here; students serve on major committees of the Board of Trustees, participate in faculty search, and contribute to strategic planning. Students participate in a wide range of extracurricular projects: The College and its surrounding community and the greater Boston area offer hundreds of internships, advocacy projects, and the rare advantages of being a vital member of the single largest academic “hotspot” in the country. Expected to be fully engaged while at Wellesley, students carry this sense of purposeful involvement and personal commitment throughout life. It is the signal mark of a Wellesley woman. A Widely Envied Campus Environment The sheer sense of scale of the breathtaking natural environment, in which buildings are thoughtfully sited, distinguish Wellesley’s physical setting in the classically New England town of Wellesley, Massachusetts, just outside of Boston. Home to leading institutions such as the Albright Institute, the Knapp Social Science Center, the Davis Museum, The Newhouse Center for the Humanities, and the world-renowned Wellesley Centers for Women, Wellesley’s resources are a magnet not only for the surrounding community and metropolitan area; they attract attention—and scholars—from around the world. Commitment to Women Everything about Wellesley College bespeaks its commitment to women, and to providing them with an unexcelled educational experience that honors and cultivates not only what is best about each of them, and their own potential, but about what women offer our world.

Rush Medical College is a school.

Memberships
Member
Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Career History
Director-Education & Training & Associate Professor
2003 - Current

The Rockefeller University (the University) is a world renowned center for research (see schedule O) and graduate education in the biomedical sciences, chemistry, bioinformatics, and physics. The University's 82 laboratories conduct both clinical and basic research and study a diverse range of biological and biomedical problems with the mission of improving the understanding of life for the benefit of humanity. Laboratories are loosely clustered in nine research areas covering a wide spectrum of disciplines in the life sciences, including neuroscience, immunology, genetics, structural biology and bioinformatics. The University does not charge tuition. Its revenues are derived primarily from investment income, government grants and contracts, and private gifts and grants.

Member-Infectious & Parasitic Disease
1994 - 2002
Director
Prior

AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.

Boards & Committees
Member, Board of Directors
2020 - Current

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.

Member, Board of Directors
2018 - Current

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The Company's key programs include: RELVAR™ or BREO™ ELLIPTA™(FF/VI), ANORO™ ELLIPTA™ (UMEC/VI) and MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist), each partnered with GlaxoSmithKline plc, and our oral Peripheral Mu Opioid Receptor Antagonist program. By leveraging its proprietary insight of multivalency to drug discovery, Theravance is pursuing a best-in-class strategy designed to discover superior medicines in areas of significant unmet medical need. Our objective is to discover, develop and commercialize new medicines with superior efficacy, convenience, tolerability and/or safety.

Chair, Institutional Review Board
Current
Independent Director
1900 - Current

The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.

Chair, Institutional Review Board
Current

The Rockefeller University (the University) is a world renowned center for research (see schedule O) and graduate education in the biomedical sciences, chemistry, bioinformatics, and physics. The University's 82 laboratories conduct both clinical and basic research and study a diverse range of biological and biomedical problems with the mission of improving the understanding of life for the benefit of humanity. Laboratories are loosely clustered in nine research areas covering a wide spectrum of disciplines in the life sciences, including neuroscience, immunology, genetics, structural biology and bioinformatics. The University does not charge tuition. Its revenues are derived primarily from investment income, government grants and contracts, and private gifts and grants.

Director
Current

AIDS VACCINE ADVOCACY COALITION (AVAC) IS AN INTERNATIONAL NON-PROFIT ORGANIZATION THAT USES PUBLIC EDUCATION, POLICY ANALYSIS, ADVOCACY AND COMMUNITY MOBILIZATION TO ACCELERATE THE ETHICAL DEVELOPMENT AND GLOBAL DELIVERY OF AIDS VACCINES AND OTHER PREVENTION TECHNOLOGIES AND INTERVENTIONS.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sarah Schlesinger. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sarah Schlesinger's profile does not indicate a business or promotional relationship of any kind between RelSci and Sarah Schlesinger.